Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a
Lotte M Kruidenier1, Saskia P Nicolaï, Ellen V Rouwet
1Department of Surgery, Orbis Medical Centre, Sittard, the Netherlands.
Summary
Adding supervised exercise therapy (SET) after percutaneous vascular intervention (PVI) significantly improves walking distance for peripheral arterial disease (PAD) patients. SET is a valuable addition to PVI for enhancing mobility and treatment outcomes.
Area of Science:
- Vascular Surgery
- Rehabilitation Medicine
- Cardiovascular Disease
Background:
- Peripheral arterial disease (PAD) significantly impairs walking ability.
- Percutaneous vascular intervention (PVI) is a common treatment for PAD.
- The role of supplemental supervised exercise therapy (SET) post-PVI requires further investigation.
Purpose of the Study:
- To compare the effectiveness of PVI combined with SET versus PVI alone in improving walking ability.
- To assess the impact of SET on absolute claudication distance (ACD) in PAD patients.
Main Methods:
- Prospective randomized trial involving 70 symptomatic PAD patients.
- Patients received PVI and were randomized to PVI alone or PVI + SET.
- Primary outcome was absolute claudication distance (ACD) measured at 6 months.
Main Results:
- The PVI + SET group showed a significantly greater mean difference in ACD (271.3 m, P = .011) compared to PVI alone.
- A higher proportion of patients in the PVI + SET group completed the treadmill test (32.4%) versus PVI alone (3.7%, P = .005).
- No significant difference in physical health-related quality-of-life scores was observed between groups (P = .34).
Conclusions:
- Supervised exercise therapy following PVI is more effective than PVI alone for increasing walking distance in PAD patients.
- SET serves as a beneficial adjunct to PVI for managing symptomatic PAD.
- These findings support the integration of SET into treatment protocols for PAD patients undergoing PVI.
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:26Peripheral Artery Disease IV: Nursing Management
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
01:30Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...